MannKind reported $10.26M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Adma Biologics USD 29.77M 9.55M Jun/2025
Dynavax Technologies USD 2.7M 1.63M Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
Halozyme Therapeutics USD 18.69M 1.38M Jun/2025
Insmed USD 78.35M 16.95M Jun/2025
MacroGenics USD 4.66M 353K Jun/2025
MannKind USD 10.26M 5.22M Jun/2025
Merck USD 4.04B 261M Jun/2025
Novo Nordisk DKK 19.58B 4.5B Mar/2025
Pfizer USD 5.17B 74M Jun/2025
Sanofi 7.08B 14.54B Jun/2025
Xencor USD 18.53M 2.34M Jun/2025